The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial (Q46678652)
Jump to navigation
Jump to search
scientific article published on 21 February 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial |
scientific article published on 21 February 2008 |
Statements
1 reference
The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial (English)
1 reference
1 reference
Steven R Steinhubl
1 reference
Robert M Califf
1 reference
Peter B Berger
1 reference
Danielle M Brennan
1 reference
Patricia J M Best
1 reference
Arijit Dasgupta
1 reference
Lynda A Szczech
1 reference
CREDO Investigators
1 reference
21 February 2008
1 reference
155
1 reference
4
1 reference
687-693
1 reference